Free Research Preview. DrugChatter may produce inaccurate information.
Save time and get answers to complex questions with AI chat
Aubagio teriflunomide availability worldwide widely available?Pembrolizumab patent expeiry data?Stelara biopharmaceutical company competitive analysis?Pembrolizumab ip end date?Fosaprepitant dimeglumine?
See the DrugPatentWatch profile for santyl
Santyl is a brand name for the drug collagenase used to help treat certain types of chronic wounds, most commonly wounds with dead tissue (necrosis/slough). It works by breaking down collagen in the damaged tissue so the wound bed can clear and heal. [1]
Santyl is indicated for debriding (removing) necrotic tissue in chronic wounds, including pressure ulcers, diabetic foot ulcers, and other types of chronic wounds where dead tissue blocks healing. [1]
Santyl is typically used as a topical ointment applied directly to the wound and is used as part of wound care. Exact instructions depend on the wound type and clinician guidance. [1]
The key point is that Santyl is an enzymatic debrider. Unlike mechanical debridement (scraping) or surgical removal, it helps loosen and remove non-viable tissue by enzymatic activity, supporting a healthier wound environment for healing. [1]
Other Questions About Santyl :